1. Hemodynamic changes in hemodialysis patients during treatment with recombinant human erythropoietin;PascualJ, TeruelJI; M, Jimenez;Nephron,1991
2. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics;Tagawa, H.; Nagano, M.; Saito, H.; Umezu, M.; Yamakado, M.;Clin Nephrol,1991
3. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure;Morris, K.P.; Skinner, JR, Hunter; S, Coulthard; M.G.;Arch Dis Child,1993
4. Regression of left ventricular hypertrophy after partial correction of anaemia with erythropoietin in patients on haemodialysis; a prospective study Clin Nephrol;Pascual, J.; Teruel, J.L.; Moya, J.L.; Liano, F.; Jimenez-Mena, M.; Ortuno, J.,1991
5. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anaemic dialysed uremic patients;Cannella, G.; La Canna, G.; Sandrini, M.;Clin Nephrol,1990